Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 51 citing articles:

Prediction of177Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study
Magdalena Mileva, Gwennaëlle Marin, Hugo Levillain, et al.
Journal of Nuclear Medicine (2023) Vol. 65, Iss. 2, pp. 236-244
Open Access | Times Cited: 24
Radiomics and Artificial Intelligence in Radiotheranostics: A Review of Applications for Radioligands Targeting Somatostatin Receptors and Prostate-Specific Membrane Antigens
Elmira Yazdani, Parham Geramifar, Najme Karamzade-Ziarati, et al.
Diagnostics (2024) Vol. 14, Iss. 2, pp. 181-181
Open Access | Times Cited: 15
Radiomics in pancreatic neuroendocrine tumors: methodological issues and clinical significance
Carolina Bezzi, Paola Mapelli, Luca Presotto, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2021) Vol. 48, Iss. 12, pp. 4002-4015
Closed Access | Times Cited: 49
[68Ga]DOTATOC PET/CT Radiomics to Predict the Response in GEP-NETs Undergoing [177Lu]DOTATOC PRRT: The “Theragnomics” Concept
Riccardo Laudicella, Albert Comelli, Virginia Liberini, et al.
Cancers (2022) Vol. 14, Iss. 4, pp. 984-984
Open Access | Times Cited: 31
68Ga-DOTATOC PET/MR imaging and radiomic parameters in predicting histopathological prognostic factors in patients with pancreatic neuroendocrine well-differentiated tumours
Paola Mapelli, Carolina Bezzi, Diego Palumbo, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2022) Vol. 49, Iss. 7, pp. 2352-2363
Closed Access | Times Cited: 30
Radionuclide Theranostics in Neuroendocrine Neoplasms: An Update
Martina Di Franco, Lucia Zanoni, Emilia Fortunati, et al.
Current Oncology Reports (2024) Vol. 26, Iss. 5, pp. 538-550
Open Access | Times Cited: 8
Early response assessment and prediction of overall survival after peptide receptor radionuclide therapy
Daphne M. V. de Vries–Huizing, Else A. Aalbersberg, Michelle W. J. Versleijen, et al.
Cancer Imaging (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 45
Peptide Receptor Radionuclide Therapy Targeting the Somatostatin Receptor: Basic Principles, Clinical Applications and Optimization Strategies
Niloefar Ahmadi Bidakhvidi, Karolien Goffin, Jeroen Dekervel, et al.
Cancers (2021) Vol. 14, Iss. 1, pp. 129-129
Open Access | Times Cited: 36
Radiolabeled Somatostatin Analogues for Diagnosis and Treatment of Neuroendocrine Tumors
Valentina Ambrosini, Lucia Zanoni, Angelina Filice, et al.
Cancers (2022) Vol. 14, Iss. 4, pp. 1055-1055
Open Access | Times Cited: 27
Management of Appendix Neuroendocrine Neoplasms: Insights on the Current Guidelines
Amr Mohamed, Sulin Wu, Mohamed E. Hamid, et al.
Cancers (2022) Vol. 15, Iss. 1, pp. 295-295
Open Access | Times Cited: 27
Application of Artificial Intelligence in Oncologic Molecular PET-Imaging: A Narrative Review on Beyond [18F]F-FDG Tracers - Part I. PSMA, Choline, and DOTA Radiotracers
Seyed Ali Mirshahvalad, Roya Eisazadeh, Malihe Shahbazi-Akbari, et al.
Seminars in Nuclear Medicine (2023) Vol. 54, Iss. 1, pp. 171-180
Open Access | Times Cited: 15
The use of PET/MRI in radiotherapy
Qi Yan, Yan Xia, Xin Yang, et al.
Insights into Imaging (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6
The Challenge of Evaluating Response to Peptide Receptor Radionuclide Therapy in Gastroenteropancreatic Neuroendocrine Tumors: The Present and the Future
Virginia Liberini, Martin W. Huellner, Séréna Grimaldi, et al.
Diagnostics (2020) Vol. 10, Iss. 12, pp. 1083-1083
Open Access | Times Cited: 37
Radiomics-Based Texture Analysis of 68Ga-DOTATATE Positron Emission Tomography and Computed Tomography Images as a Prognostic Biomarker in Adults With Neuroendocrine Cancers Treated With 177Lu-DOTATATE
Charlotte Atkinson, Balaji Ganeshan, Raymond Endozo, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 32
Impact of segmentation and discretization on radiomic features in 68Ga-DOTA-TOC PET/CT images of neuroendocrine tumor
Virginia Liberini, Bruno De Santi, Osvaldo Rampado, et al.
EJNMMI Physics (2021) Vol. 8, Iss. 1
Open Access | Times Cited: 28
Heterogeneity of SSTR2 Expression Assessed by 68Ga-DOTATOC PET/CT Using Coefficient of Variation in Patients with Neuroendocrine Tumors
Rosa Fonti, Mariarosaria Panico, Sara Pellegrino, et al.
Journal of Nuclear Medicine (2022) Vol. 63, Iss. 10, pp. 1509-1514
Open Access | Times Cited: 20
Nuclear Medicine and Radiological Imaging of Pancreatic Neuroendocrine Neoplasms: A Multidisciplinary Update
Daniela Prosperi, Guido Gentiloni Silveri, Francesco Panzuto, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 22, pp. 6836-6836
Open Access | Times Cited: 15
Radioligand therapy in the therapeutic strategy for patients with gastro-entero-pancreatic neuroendocrine tumors: a consensus statement from the Italian Association for Neuroendocrine Tumors (Itanet), Italian Association of Nuclear Medicine (AIMN), Italian Society of Endocrinology (SIE), Italian Association of Medical Oncology (AIOM).
Francesco Panzuto, Manuela Albertelli, Maria Luisa De Rimini, et al.
Journal of Endocrinological Investigation (2024) Vol. 48, Iss. 1, pp. 23-36
Open Access | Times Cited: 3
Challenges in developing response evaluation criteria for peptide receptor radionuclide therapy: A consensus report from the European Neuroendocrine Tumor Society Advisory Board Meeting 2022 and the ENETS Theranostics Task Force
Vikas Prasad, Anna Koumarianou, Timm Denecke, et al.
Journal of Neuroendocrinology (2024)
Open Access | Times Cited: 3
Imaging and liquid biopsy in the prediction and evaluation of response to PRRT in neuroendocrine tumors: implications for patient management
Wolfgang Roll, Matthias Weckesser, Robert Seifert, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2021) Vol. 48, Iss. 12, pp. 4016-4027
Open Access | Times Cited: 19
Target Heterogeneity in Oncology: The Best Predictor for Differential Response to Radioligand Therapy in Neuroendocrine Tumors and Prostate Cancer
Ameya Puranik, Clarisse Dromain, Neil Fleshner, et al.
Cancers (2021) Vol. 13, Iss. 14, pp. 3607-3607
Open Access | Times Cited: 19
Preoperative assessment of lymph nodal metastases with [68Ga]Ga-DOTATOC PET radiomics for improved surgical planning in well-differentiated pancreatic neuroendocrine tumours
Paola Mapelli, Carolina Bezzi, Francesca Muffatti, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2024) Vol. 51, Iss. 9, pp. 2774-2783
Closed Access | Times Cited: 2
Advancements in Neuroendocrine Neoplasms: Imaging and Future Frontiers
Luigi Asmundo, Francesco Rizzetto, Michael A. Blake, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 11, pp. 3281-3281
Open Access | Times Cited: 2
68Ga-DOTATOC PET/CT-Based Radiomic Analysis and PRRT Outcome: A Preliminary Evaluation Based on an Exploratory Radiomic Analysis on Two Patients
Virginia Liberini, Osvaldo Rampado, E. Gallio, et al.
Frontiers in Medicine (2021) Vol. 7
Open Access | Times Cited: 15
Added Value of Tomoelastography for Characterization of Pancreatic Neuroendocrine Tumor Aggressiveness Based on Stiffness
Emin Yener Gültekin, Christoph Wetz, Jürgen Braun, et al.
Cancers (2021) Vol. 13, Iss. 20, pp. 5185-5185
Open Access | Times Cited: 15
Page 1 - Next Page

Scroll to top